Search
for
Sort by
Research 631–660 of 1000+
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Medikamentöse Therapie der BPH Ist eine Kombinationstherapie mit 5α-Reduktasehemmern und α-Rezeptorenblockern sinnvoll?
- Editorial comment 1
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Experimental Assessment of 3-<i>meta</i>-Pyridine-1,2,4-Oxadiazole Deoxycholic Acid Derivative as a Prototype of 5-α-Reductase Inhibitors <i>in silico</i> and <i>in vivo</i> Models
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
- THE ROLE Of 5αR AND α1AR INHIBITORS IN MANAGEMENT OF BPH
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- 5α-reductase activity in the prostate
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase
- Sponsored Lecture 3 : Updates on 5 alpha-rers(5ARIs) for the treatment of male pattern hair loss(MPHL)
- Economic Issues in the Treatment of BPH
- Prescribing to save patients money: Ethical considerations
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Association of Frailty Index with Clinical BPH Progression and Serious Adverse Events: the MTOPS Trial
- BPH Medications May Increase Risk of Self-Harm, Depression
- Experience of using of Sonirid Duo in treatment of patients with BPH
- Glatze in jungen Jahren könnte Risikofaktor für BPH sein
- Long-Term Effectiveness of Finasteride for BPH
- Effects of 5-?±-Reductase Inhibitor (Finasteride) on Per Operative Blood Loss in Patients with BPH undergoing TURP
- Cost-minimization Analysis of 2 Drug Therapy Projects Including Traditional Chinese Medcines and Chemical Medcines in BPH Patients
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Effects of 5-alpha reductase inhibitors
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Інгібітор 5α-редуктази дутастерид при лікуванні доброякісної гіперплазії передміхурової залози: системний огляд та мета-аналіз
- 1640: Polymorphisms in the 5α-Reductase Type 2 Gene and Response to Finasteride Treatment in BPH
- Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.